e.g. Tata motors, Reliance MF, 500570

Marksans Pharma Ltd. - Research Center

524404 MARKSANS Group (A) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21
Income
Operating income 1,174.37 853.27 655.20 658.29 599.55
Expenses
Material consumed 639.94 478.94 394.45 377.59 337.91
Manufacturing expenses 30.73 26.04 14.24 11.27 10.90
Personnel expenses 101.68 77.19 56.09 60.46 54.64
Selling expenses - - - - -
Adminstrative expenses 197.98 131.17 98.52 95.25 82.38
Expenses capitalised - - - - -
Cost of sales 970.32 713.34 563.30 544.57 485.84
Operating profit 204.05 139.94 91.90 113.72 113.71
Other recurring income 69.83 62.07 60.48 42.25 31.16
Adjusted PBDIT 273.89 202.01 152.39 155.97 144.87
Financial expenses 1.17 0.99 3.61 3.80 5.34
Depreciation 29.45 29.13 16.74 17.66 15.19
Other write offs - - - - -
Adjusted PBT 243.26 171.89 132.04 134.51 124.33
Tax charges 54.99 38.13 29.17 30.52 25.95
Adjusted PAT 188.27 133.76 102.87 103.99 98.38
Non recurring items -0.30 0.28 -0.59 0.05 -0.20
Other non cash adjustments - - - - -
Reported net profit 187.97 134.04 102.28 104.03 98.19
Earnigs before appropriation 532.97 367.65 257.48 165.44 65.50
Equity dividend 27.19 22.66 10.17 10.23 4.09
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 505.78 345.00 247.31 155.21 61.41
Close
Add Marksans Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Marksans Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback